Heidi J. Gray, MD
Associate Professor, Division of Gynecologic Oncology
University of Washington Medical Center
Box 356460
Seattle,
WA
USA
98195
Papers:
131 - Focused Plenary
A phase I study of veliparib (ABT-888) in combination with carboplatin and gemcitabine in subjects with advanced ovarian cancer
136 - Scientific Plenary
A phase II evaluation of the potent, highly selective PARP inhibitor veliparib in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who carry a germline BRCA1 or BRCA2 m
244 - Poster Session A
Prognostic factors for overall survival in recurrent ovarian, Fallopian tube, and peritoneal cancer patients treated with bevacizumab: a multisite study